Specifications

Experimental features
Cross-sectional population study
Data source location Oslo, Norway Data accessibility Data is with this article
Value of the data
Extensive clinical information and imaging data on study subjects. Extensive information on exercise habits and clinical endpoints in our hypertrophic cardiomyopathy study cohort.
Physical exercise questionnaire used in the survey Complete genetic information on all mutations in our hypertrophic cardiomyopathy study cohort, with potential for pooling of data and study mutation-specific variations in phenotypic expression.
Data
The data presented in this article are supplementary material to our study on vigorous exercise in hypertrophic cardiomyopathy patients. [1] . Fig. A .1 displays study flowchart and A.2 and A.3 represent the letter and the physical activity questionnaire sent to study participants. Tables B.1 and B.2 are logistic regression models presenting markers of hypertrophic cardiomyopathy phenotype and ventricular arrhythmias. Table B .3 presents specific information on genetic mutations. Table B .4 contains clinical and imaging data related to hypertrophic cardiomyopathy phenotype and exercise status. Table B .5 shows additional exercise data.
Experimental design, materials and methods
The study design was cross-sectional. Time of study inclusion was the first clinical evaluation and echocardiogram in the outpatient clinic, Unit for Genetic Cardiac Diseases, Department of Cardiology, Oslo University Hospital, Rikshospitalet, Norway (Fig. A.1 ). Hypertrophic cardiomyopathy genotype positive, phenotype negative (Genotypeþ LVH-) and hypertrophic cardiomyopathy phenotype positive (HCM LVHþ) patients were included. Inclusion commenced in 2001 and ended in 2015 [1] .
In May 2015 we cross checked the HCM cohort against the Norwegian death registry and found 14 deaths, of which cause of death was documented for all cases in the medical journals, and is reproduced in Fig. A.1 . During May 2015 we completed a physical activity survey via letter (A.2 and A.3) among the 260 live subjects enrolled in our HCM cohort. Non-responders were contacted by phone and offered the possibility of completing the physical activity questionnaire via structured interview (A.3).
Study participants who were actively participating in organized or competitive sports at study inclusion, were defined as competitive athletes. 
Funding sources
Chr11(GRCh37):g.47372934_47372936del rs781207661 2 MYH7 NM_000257.2 p.T1377M c.4130C 4T Chr14(GRCh37):g.23887458G 4A rs397516201 2 MYH7 NM_000257.2 p.V606M c.1816G4A Chr14(GRCh37):g.23896866C 4T rs121913627 2 MYH7 NM_000257.2 p.D554E c.1662C 4A Chr14(GRCh37):g.23897020G 4 T rs750828477 2 TINNI3 NM_000363.4 p.D196N c.586G 4 A Chr19(GRCh37):g.55663249C 4 T rs104894727 2 MYBPC3 NM_000256.3 p.Y237S c.710A 4C Chr11(GRCh37):g.47370037T4 G rs397516070 1 MYBPC3 NM_000256.3 p.L1238P c.3713T4C Chr11(GRCh37):g.47353724A4 G rs730880702 1 MYBPC3 NM_000256.3 p.Q998E c.2992C 4G Chr11(GRCh37):g.47355475G 4 C rs11570112 1 MYBPC3 NM_000256.3 p.
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